Literature DB >> 28623619

Development of Chinese medicine research in Hong Kong, China in last decade.

Ai-Ping Lu1, Shi-Ping Cheng2,3, Biao Liu2.   

Abstract

Mesh：

Year:  2017        PMID： 28623619     DOI： 10.1007/s11655-017-2816-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  5 in total

1.  AGREE II: advancing guideline development, reporting, and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  Prev Med       Date:  2010-08-20       Impact factor: 4.018

2.  Differential effects of anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive fractions on human colorectal cancer models.

Authors:  E S M Chu; S C W Sze; H P Cheung; K L Wong; Q Liu; T B Ng; Y Tong
Journal:  J Ethnopharmacol       Date:  2011-06-06       Impact factor: 4.360

Review 3.  Appraisal of clinical practice guidelines for ischemic stroke management in Chinese medicine with appraisal of guidelines for research and evaluation instrument: A systematic review.

Authors:  Ya Yuwen; Nan-nan Shi; Xue-Jie Han; Ying Gao; Jian-long Xu; Da-sheng Liu; Bacon Ng; Dora Tsui; Li-dan Zhong; Eric Ziea; Zhao-xiang Bian; Ai-ping Lu
Journal:  Chin J Integr Med       Date:  2014-06-18       Impact factor: 1.978

4.  Chinese herbal medicine (Ma Zi Ren Wan) for functional constipation: study protocol for a prospective, double-blinded, double-dummy, randomized controlled trial.

Authors:  Linda L D Zhong; Chung Wah Cheng; Yawen Chan; King Hong Chan; Ting Wa Lam; Xiao Rui Chen; Chi Tak Wong; Justin C Y Wu; Zhao Xiang Bian
Journal:  Trials       Date:  2013-11-04       Impact factor: 2.279

5.  Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine.

Authors:  Cheng Wang; Biao Liu; Xuelian Xu; Bo Zhuang; Hongxia Li; Jiaqi Yin; Mengyi Cong; Wei Xu; Aiping Lu
Journal:  Oncotarget       Date:  2016-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.